‘You’ve Got to be Freaking Kidding Me’: U.S. Military Spends Over $700 Million for Ozempic and Other GLP-1 Weight Loss Meds
Subsequent to this report, Secretary of War Pete Hegseth expressed his concern on X, stating, “Completely unacceptable. This is what happens when standards are IGNORED – and this is what we are changing. REAL fitness & weight standards are here. We will be FIT, not FAT.”
Was the solution found in raising the bar for “REAL fitness & weight standards?” Perhaps they were. However, some startling revelations concerning weight loss have emerged, with RealClearInvestigations dubbing this disclosure the “Waste of the Day.”
Since 2021, the military has allocated nearly $726 million for Ozempic and other GLP-1 weight loss medications, with $274.6 million spent in fiscal year 2025, as revealed by spending records acquired by Open the Books.
This expenditure encompasses 102,597 individual purchases, all made through the Defense Logistics Agency for “troop support.” The majority of the funds were directed to the wholesale pharmaceutical company Cencora. Over a dozen varieties of GLP-1 medications were acquired, including Wegovy, Mounjaro, and Trulicity.
Many individuals—and taxpayers alike—who have served in the military are infuriated.
Lt. Ted Macie, a retired Navy Medical Service Corps officer, was appalled. He informed The Gateway Pundit that data obtained from the Defense Medical Epidemiology Database (DMED) indicate that obesity rates have surged in the military over the last decade.
From 2016 to 2019, an average of 13,863 cases of overweight and obesity were documented across all branches of service. This average rose to 21,969 between 2020 and 2023. Remarkably, there was a 190 percent increase during this period, with cases soaring from 12,249 to 35,531.
Macie criticized the use of Ozempic and other GLP-1 medications as “yet another bandage on a broken leg, and this one comes with a nearly billion-dollar tax burden and for avoidable poor choices.” He has long been an advocate for fitness and nutrition, both personally and as a command fitness leader.
“It’s frustrating to watch policies that miss the mark while service members pay the price,” he lamented. “There are well-documented, life-altering side effects like bone and muscle loss, vision issues, kidney problems, the kind of things you don’t just cure at the next Physical Readiness test.”
Macie argued that the military’s message is contradictory. When overweight service members are regularly promoted and seen throughout installations, he said, it undermines any genuine assertion that readiness and health are important. “These commanders can’t preach fitness while rewarding the opposite.”
In his view, the military’s investment of $726 million in what is essentially a temporary “fix” is “very shortsighted.”
“Odds are, we’ll be paying for the downstream health consequences later, too,” he admitted. “It continues to display the power of the relationship with the pharmaceutical industry and the military.”
In conclusion, Macie remarked, this is “par for the course, unfortunately.”
https://www.americansecurityproject.org/wp-content/uploads/2025/04/Ref-0301-Ready-the-Reserve-Obesitys-Impacts-on-National-Guard-and-Reserve-Readiness.pdf